Cardio thanks for that info and I will have to go back to look at that but JT may price it higher in the EU but it seems as though in that case that V won’t be covered by govt health plans.
Cardio / Montana ...AMRN can charge whatever they like ( ie higher prices ) in the EU if they want ....it doesn't matter . Its the individual country reimbursement policy that counts when most of the drugs are dispensed thru individual govt health agencies.
.
So a country like Germany may have a generous reimbursement policy where as a country like Poland may refuse to reimburse any of the cost ....ie the patient, if he/she wants Vascepa ,they pay full retail price.
I have no guess on EU revenues . I think it will be a slow country by country process to determine which countries AMRN can make $ in..... and which they can't.
I think the current PPS reflects and largely discounts, the challenges ahead .